CVE-2023-41089: Dexma Dexgate

High severity, CVSS 8.8. EPSS: 0.5% chance of exploitation in the next 30 days.

The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to impersonate a legitimate user as long as the device keeps the session active, since the attack takes advantage of the cookie header to generate "legitimate" requests.

Affected products

• Dexma Dexgate: version 20130114 only

Published 2023-10-19. Last modified 2026-06-17.